Wells Fargo & Company Chimerix Inc Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Chimerix Inc stock. As of the latest transaction made, Wells Fargo & Company holds 28,738 shares of CMRX stock, worth $26,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,738

Previous 19,384 48.26%

Holding current value

$26,438

Previous $20,000 25.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.87 - $1.05 $8,137 - $9,821	9,354 Added 48.26%	28,738 $25,000
Q1 2024 May 10, 2024	BUY	$0.91 - $1.26 $17,051 - $23,609	18,738 Added 2900.62%	19,384 $20,000
Q4 2023 Feb 09, 2024	BUY	$0.9 - $1.06 $31 - $37	35 Added 5.73%	646 $0
Q3 2023 Nov 13, 2023	SELL	$0.94 - $1.23 $25 - $33	-27 Reduced 4.23%	611 $0
Q2 2023 Aug 15, 2023	SELL	$1.1 - $1.54 $16,750 - $23,451	-15,228 Reduced 95.98%	638 $0
Q1 2023 May 12, 2023	BUY	$1.19 - $2.09 $18,880 - $33,159	15,866 New	15,866 $19,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $4,932 - $7,520	-2,725 Reduced 70.82%	1,123 $2,000
Q2 2022 Aug 12, 2022	SELL	$1.34 - $5.34 $131,427 - $523,747	-98,080 Reduced 96.22%	3,848 $8,000
Q1 2022 May 16, 2022	SELL	$4.58 - $6.8 $43,193 - $64,130	-9,431 Reduced 8.47%	101,928 $467,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $1.22 Million - $1.68 Million	-233,362 Reduced 67.7%	111,359 $716,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $721,781 - $1.06 Million	-121,512 Reduced 26.06%	344,721 $2.13 Million
Q2 2021 Aug 16, 2021	SELL	$7.54 - $9.79 $56,029 - $72,749	-7,431 Reduced 1.57%	466,233 $3.73 Million
Q1 2021 May 13, 2021	BUY	$4.76 - $11.25 $1.51 Million - $3.57 Million	316,901 Added 202.15%	473,664 $4.57 Million
Q4 2020 Feb 09, 2021	BUY	$2.43 - $5.42 $29,342 - $65,446	12,075 Added 8.35%	156,763 $757,000
Q3 2020 Nov 05, 2020	BUY	$2.3 - $3.72 $67,953 - $109,907	29,545 Added 25.66%	144,688 $360,000
Q2 2020 Aug 13, 2020	BUY	$1.33 - $3.63 $87,213 - $238,033	65,574 Added 132.29%	115,143 $357,000
Q1 2020 May 14, 2020	BUY	$1.27 - $2.33 $62,952 - $115,495	49,569 New	49,569 $71,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $80.6M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Chimerix Inc Transaction History